To evaluate the role of systemic treatment in the multidisciplinary approach and treatment decisions for patients with brain metastases (BM), highlighting its significance in optimizing patient outcomes.
Key Findings:
676 patients with BM were included, with a median follow-up of 43 months. Treatment decisions varied significantly based on clinical parameters and multidisciplinary evaluations, indicating the need for tailored approaches.
Interpretation:
The study highlights the complexity of treatment decisions for BM, emphasizing the need for individualized approaches based on predictive parameters and multidisciplinary input, which can significantly impact patient outcomes.
Limitations:
Retrospective design may introduce selection bias.
Single-center study limits generalizability of findings.
Variability in treatment protocols and patient characteristics may affect outcomes, and potential biases in data collection methods should be considered.
Conclusion:
Optimizing treatment for brain metastases requires careful consideration of systemic treatment options and individual patient factors, underscoring the importance of a multidisciplinary approach and the need for ongoing research in this area.
